These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29893406)

  • 1. Pharmacokinetics of low-dose methotrexate in healthy beagle dogs.
    Rostang A; Mosca M; Jeannin M; Luissiez C; Berny P; Fourel I; Pin D; Prouillac C
    J Vet Pharmacol Ther; 2018 Oct; 41(5):659-669. PubMed ID: 29893406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate.
    Pichlmeier U; Heuer KU
    Clin Exp Rheumatol; 2014; 32(4):563-71. PubMed ID: 24983446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.
    Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Subcutaneous Methotrexate in Chronic Plaque Psoriasis.
    Yesudian PD; Leman J; Balasubramaniam P; Macfarlane AW; Al-Niaimi F; Griffiths CE; Burden AD; Warren RB
    J Drugs Dermatol; 2016 Mar; 15(3):345-9. PubMed ID: 26954320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of low doses of methotrexate in patients with psoriasis over the early period of treatment.
    Chládek J; Martínková J; Simková M; Vanecková J; Koudelková V; Nozicková M
    Eur J Clin Pharmacol; 1998 Feb; 53(6):437-44. PubMed ID: 9551702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis.
    Tuková J; Chládek J; Nemcová D; Chládková J; Dolezalová P
    Clin Exp Rheumatol; 2009; 27(6):1047-53. PubMed ID: 20149329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and Acid Suppressant Efficacy of Esomeprazole after Intravenous, Oral, and Subcutaneous Administration to Healthy Beagle Dogs.
    Hwang JH; Jeong JW; Song GH; Koo TS; Seo KW
    J Vet Intern Med; 2017 May; 31(3):743-750. PubMed ID: 28407418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M
    Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration.
    Bianchi G; Caporali R; Todoerti M; Mattana P
    Adv Ther; 2016 Mar; 33(3):369-78. PubMed ID: 26846283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic studies of methotrexate in plasma and synovial fluid following i.v. bolus and topical routes of administration in dogs.
    Lu GW; Jun HW; Dzimianski MT; Qiu HC; McCall JW
    Pharm Res; 1995 Oct; 12(10):1474-7. PubMed ID: 8584484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing.
    Jundt JW; Browne BA; Fiocco GP; Steele AD; Mock D
    J Rheumatol; 1993 Nov; 20(11):1845-9. PubMed ID: 8308768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate: bioavailability and pharmacokinetics.
    Campbell MA; Perrier DG; Dorr RT; Alberts DS; Finley PR
    Cancer Treat Rep; 1985; 69(7-8):833-8. PubMed ID: 3893694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease.
    Wilson A; Patel V; Chande N; Ponich T; Urquhart B; Asher L; Choi Y; Tirona R; Kim RB; Gregor JC
    Aliment Pharmacol Ther; 2013 Feb; 37(3):340-5. PubMed ID: 23190184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
    Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
    Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of low-dose methotrexate in horses.
    Rostang A; Desjardins I; Espana B; Panzuti P; Berny P; Prouillac C; Pin D
    J Vet Pharmacol Ther; 2020 Sep; 43(5):461-469. PubMed ID: 32216109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of levofloxacin after single intravenous, oral and subcutaneous administration to dogs.
    Landoni MF; Albarellos GA
    J Vet Pharmacol Ther; 2019 Mar; 42(2):171-178. PubMed ID: 30302775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis.
    Schiff MH; Sadowski P
    Rheumatol Int; 2017 Feb; 37(2):213-218. PubMed ID: 28012023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.